Inventor
KEIL BIRGIT
DE16 patents
⚠️ This page may combine multiple inventors who share the name “KEIL BIRGIT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ADVERIO PHARMA GMBH
4 patentsUS11203593B2Dec 21, 2021
Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
ADVERIO PHARMA GMBH2 citations72
US12503469B2Dec 23, 2025
Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate
ADVERIO PHARMA GMBH0 citations62
US10087183B2Oct 2, 2018
Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate
ADVERIO PHARMA GMBH1 citations62
US10662188B2May 26, 2020
Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate
ADVERIO PHARMA GMBH0 citations51
GRUNENBERG ALFONS
3 patentsUS8466280B2Jun 18, 2013
Co-crystal compound of rivaroxaban and malonic acid
GRUNENBERG ALFONS18 citations84
US9957232B2May 1, 2018
4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrate
GRUNENBERG ALFONS2 citations66
US8188270B2May 29, 2012
Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
GRUNENBERG ALFONS4 citations57
AICURIS GMBH & CO KG
2 patentsUS9637459B2May 2, 2017
Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents
AICURIS GMBH & CO KG4 citations71
US9340535B2May 17, 2016
N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate
AICURIS GMBH & CO KG5 citations71
PH PHARMA CO LTD
2 patentsUS10316001B2Jun 11, 2019
Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile
PH PHARMA CO LTD1 citations59
US10676443B2Jun 9, 2020
Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile
PH PHARMA CO LTD0 citations49
BAYER AG
2 patentsUS12202805B2Jan 21, 2025
Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound
BAYER AG0 citations56
US12138256B2Nov 12, 2024
Treatment of cardiopulmonary disorders
BAYER AG0 citations54